Browsing by Author Basappa

Showing results 1 to 5 of 5
Issue DateTitleAuthor(s)
2012Anti-cancer activity of novel dibenzo[b,f]azepine tethered isoxazoline derivativesSadashiva, M.P.; Basappa; Nanjundaswamy, S.; Li, F.; Manu, K.A. ; Sengottuvelan, M.; Prasanna, D.S.; Anilkumar, N.C.; Sethi, G.; Sugahara, K.; Rangappa, K.S.
2010Cheminformatics-based drug design approach for identification of inhibitors targeting the characteristic residues of mmp-13 hemopexin domainKothapalli R.; Khan A.M.; Basappa; Gopalsamy A.; Chong Y.S. ; Annamalai L.
2016Novel Synthetic Oxazines Target NF-κB in Colon Cancer In Vitro and Inflammatory Bowel Disease In VivoNirvanappa A.C.; Mohan C.D.; Rangappa S.; Ananda H.; Sukhorukov A.Y.; Shanmugam M.K.; Sundaram M.S.; Nayaka S.C.; Girish K.S.; Chinnathambi A.; Zayed M.E.; Alharbi S.A.; Sethi G. ; Basappa; Rangappa K.S.
2014Synthesis and characterization of novel 2-amino-chromene-nitriles that target Bcl-2 in acute myeloid leukemia cell linesKeerthy H.K.; Garg M. ; Mohan C.D.; Madan V. ; Kanojia D. ; Shobith R.; Nanjundaswamy S.; Mason D.J.; Bender A.; Basappa; Rangappa K.S.; Koeffler H.P. 
2016Trisubstituted-imidazoles induce apoptosis in human breast cancer cells by targeting the oncogenic PI3K/Akt/mTOR signaling pathwayMohan C.D.; Srinivasa V.; Rangappa S.; Mervin L.; Mohan S.; Paricharak S.; Baday S.; Li F. ; Shanmugam M.K. ; Chinnathambi A.; Zayed M.E.; Alharbi S.A.; Bender A.; Sethi G. ; Basappa; Rangappa K.S.